(Q48234619)

9 February 2018

title

Distribution of clozapine and desmethylclozapine between blood and brain in rats (English)

1 reference

9 February 2018

author name string

H Weigmann

1

1 reference

9 February 2018

S Härtter

2

1 reference

9 February 2018

V Fischer

3

1 reference

9 February 2018

N Dahmen

4

1 reference

9 February 2018

C Hiemke

5

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

9 February 2018

European Neuropsychopharmacology

published in

1 reference

9 February 2018

volume

9

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

253-256

1 reference

9 February 2018

Clozapine. A novel antipsychotic agent

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Tissue concentrations of clozapine and its metabolites in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Multiple-dose pharmacokinetics of clozapine in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

EEG alterations in patients treated with clozapine in relation to plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Leponex--associated granulocytopenia: a review of the situation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Disposition of clozapine and desmethylclozapine in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

Automated Determination of Clozapine and Major Metabolites in Serum and Urine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900036-4

7 January 2021

10.1016/S0924-977X(98)00036-4

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018